Top

Published in:

01-08-2006 | Original Paper

A Prospective Study of Dietary Alpha-linolenic Acid and the Risk of Prostate Cancer (United States)

Authors: Daniel O. Koralek, Ulrike Peters, Gerald Andriole, Douglas Reding, Victoria Kirsh, Amy Subar, Arthur Schatzkin, Richard Hayes, Michael F. Leitzmann

Published in: Cancer Causes & Control | Issue 6/2006

Abstract

Background

Alpha-linolenic acid (ALA) is the most common omega-3 fatty acid in the Western diet. The relation of dietary intake of ALA to prostate cancer risk remains unresolved.

Objective

We prospectively evaluated total ALA and ALA from specific food sources including animal, fish, and plant sources in relation to prostate cancer risk.

Design

A cohort of 29,592 male participants (age 55–74 years) in the screening arm of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial was followed for an average of 5.1 years.

Results

We ascertained 1,898 cases of total prostate cancer, of which 1,631 were organ-confined cases (stage T1b to T3a and N0M0) and 285 were advanced stage cases (stage≥T3b, N1, or M1). We found no association between total ALA intake and overall prostate cancer (multivariate RR comparing extreme quintiles=0.94; 95% CI=0.81–1.09; P for trend=0.76). The corresponding RRs for organ-confined and advanced prostate cancer were 0.94 (95% CI=0.80–1.10; P for trend=0.80) and 0.83 (95% CI=0.58–1.19; P for trend=0.34), respectively. In addition, no relations were observed between ALA intake from any specific food source and the risks of total, organ-confined, or advanced prostate cancer. ALA intake also showed no association with low grade (Gleason sum<7; 1,221 cases) tumors (P for trend=0.23) or high grade (Gleason sum≥7; n=677 cases) tumors (P for trend=0.26).

Conclusions

In this prospective study of predominantly Caucasian men who were screened annually for newly incident prostate cancer, dietary intake of total ALA and ALA from specific food sources was not associated with risk of total prostate cancer or prostate tumors that were defined by stage and grade.

De Stefani, E, Deneo-Pellegrini, H, Boffetta, P, Ronco, A, Mendilaharsu, M 2000Alpha-linolenic acid and risk of prostate cancer: a case-control study in UruguayCancer Epidemiol Biomarkers Prev9335338PubMed

Leitzmann, MF, Stampfer, MJ, Michaud, DS, Augustsson, K, Colditz, GC, Willett, WC, Giovannucci, EL 2004Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancerAm J Clin Nutr80204216PubMed

Giovannucci, E, Rimm, EB, Colditz, GA, Stampfer, MJ, Ascherio, A, Chute, CC, Willett, WC 1993A prospective study of dietary fat and risk of prostate cancerJ Natl Cancer Inst8515711579PubMed

Harvei, S, Bjerve, KS, Tretli, S, Jellum, E, Robsahm, TE, Vatten, L 1997Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancerInt J Cancer71545551PubMedCrossRef

Gann, PH, Hennekens, CH, Sacks, FM, Grodstein, F, Giovannucci, EL, Stampfer, MJ 1994Prospective study of plasma fatty acids and risk of prostate cancerJ Natl Cancer Inst86281286PubMed

Ramon, JM, Bou, R, Romea, S, Alkiza, ME, Jacas, M, Ribes, J, Oromi, J 2000Dietary fat intake and prostate cancer risk: a case-control study in SpainCancer Causes Control11679685PubMedCrossRef

Yang, YJ, Lee, SH, Hong, SJ, Chung, BC 1999Comparison of fatty acid profiles in the serum of patients with prostate cancer and benign prostatic hyperplasiaClin Biochem32405409PubMedCrossRef

Newcomer, LM, King, IB, Wicklund, KG, Stanford, JL 2001The association of fatty acids with prostate cancer riskProstate47262268PubMedCrossRef

Godley, PA, Campbell, MK, Gallagher, P, Martinson, FE, Mohler, JL, Sandler, RS 1996Biomarkers of essential fatty acid consumption and risk of prostatic carcinomaCancer Epidemiol Biomarkers Prev5889895PubMed

10.

Mannisto, S, Pietinen, P, Virtanen, MJ, Salminen, I, Albanes, D, Giovannucci, E, Virtamo, J 2003Fatty acids and risk of prostate cancer in a nested case-control study in male smokersCancer Epidemiol Biomarkers Prev1214221428PubMed

11.

Laaksonen, DE, Laukkanen, JA, Niskanen, L, Nyyssonen, K, Rissanen, TH, Voutilainen, S, Pukkala, E, Hakkarainen, A, Salonen, JT 2004Serum linoleic and total polyunsaturated fatty acids in relation to prostate and other cancers: a population-based cohort studyInt J Cancer111444450PubMedCrossRef

12.

Andersson, SO, Wolk, A, Bergstrom, R, Giovannucci, E, Lindgren, C, Baron, J, Adami, HO 1996Energy, nutrient intake and prostate cancer risk: a population-based case-control study in SwedenInt J Cancer68716722PubMedCrossRef

13.

Bairati, I, Meyer, F, Fradet, Y, Moore, L 1998Dietary fat and advanced prostate cancerJ Urol15912711275PubMedCrossRef

14.

Meyer, F, Bairati, I, Fradet, Y, Moore, L 1997Dietary energy and nutrients in relation to preclinical prostate cancerNutr Cancer29120126PubMed

15.

Mamalakis, G, Kafatos, A, Kalogeropoulos, N, Andrikopoulos, N, Daskalopulos, G, Kranidis, A 2002Prostate cancer vs hyperplasia: relationships with prostatic and adipose tissue fatty acid compositionProstaglandins Leukot Essent Fatty Acids66467477PubMedCrossRef

16.

Schuurman, AG, Brandt, PA, Dorant, E, Brants, HA, Goldbohm, RA 1999Association of energy and fat intake with prostate carcinoma risk: results from The Netherlands Cohort StudyCancer8610191027PubMedCrossRef

17.

Freeman, VL, Meydani, M, Yong, S, Pyle, J, Flanigan, RC, Waters, WB, Wojcik, EM 2000Prostatic levels of fatty acids and the histopathology of localized prostate cancerJ Urol16421682172PubMedCrossRef

18.

Raper, NR, Cronin, FJ, Exler, J 1992Omega-3 fatty acid content of the US food supplyJ Am Coll Nutr11304308PubMed

19.

Kris-Etherton, PM, Taylor, DS, Yu-Poth, S, Huth, P, Moriarty, K, Fishell, V, Hargrove, RL, Zhao, G, Etherton, TD 2000Polyunsaturated fatty acids in the food chain in the United StatesAm J Clin Nutr71179S188SPubMed

20.

Sprecher, H 1996New advances in fatty-acid biosynthesisNutrition12S5S7PubMed

21.

Saito, M, Kubo, K 2003Relationship between tissue lipid peroxidation and peroxidizability index after alpha-linolenic, eicosapentaenoic, or docosahexaenoic acid intake in ratsBr J Nutr891928PubMedCrossRef

22.

Healy, DA, Wallace, FA, Miles, EA, Calder, PC, Newsholm, P 2000Effect of low-to-moderate amounts of dietary fish oil on neutrophil lipid composition and functionLipids35763768PubMed

23.

Calder, PC 2001Omega 3 polyunsaturated fatty acids, inflammation and immunityWorld Rev Nutr Diet88109116PubMedCrossRef

24.

Attar-Bashi, NM, Frauman, AG, Sinclair, AJ 2004Alpha-linolenic acid and the risk of prostate cancer. What is the evidence?J Urol17114021407PubMedCrossRef

25.

Brouwer, IA, Katan, MB, Zock, PL 2004Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysisJ Nutr134919922PubMed

26.

Michaud, DS, Augustsson, K, Rimm, EB, Stampfer, MJ, Willet, WC, Giovannucci, E 2001A prospective study on intake of animal products and risk of prostate cancerCancer Causes Control12557567PubMedCrossRef

27.

Gohagan, JK, Prorok, PC, Hayes, RB, Kramer, BS 2000The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and statusControl Clin Trials21251S272SPubMedCrossRef

28.

Subar, AF, Midthune, D, Kulldorff, M, Brown, CC, Thompson, FE, Kipnis, V, Schatzkin, A 2000Evaluation of alternative approaches to assign nutrient values to food groups in food frequency questionnairesAm J Epidemiol152279286PubMedCrossRef

29.

Subar, AF, Thompson, FE, Smith, AF, Jobe, JB, Ziegler, RG, Potischman, N, Schatzkin, A, Hartman, A, Swanson, C, Kruse, L, et al. 1995Improving food frequency questionnaires: a qualitative approach using cognitive interviewingJ Am Diet Assoc95781788quiz 789–790PubMedCrossRef

30.

Thompson, FE, Subar, AF, Brown, CC, Smith, AF, Sharbaugh, CO, Jobe, JB, Mittl, B, Gibson, JT, Ziegler, RG 2002Cognitive research enhances accuracy of food frequency questionnaire reports: results of an experimental validation studyJ Am Diet Assoc102212225PubMedCrossRef

31.

Prorok, PC, Andriole, GL, Bresalier, RS, Buys, SS, Chia, D, Crawford, ED, Fogel, R, Gelmann, EP, Gilbert, F, Hasson, MA, Hayes, RB, Johnson, CC, Mandel, JS, Oberman, A, O’Brien, B, Oken, MM, Rafla, S, Reding, D, Rutt, W, Weissfeld, JL, Yokochi, L, Gohagan, JK 2000Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening TrialControl Clin Trials21273S309SPubMedCrossRef

32.

Whittemore, AS, Kolonel, LN, Wu, AH, John, EM, Gallagher, RP, Howe, GR, Burch, JD, Hankin, J, Dreon, DM, West, DW 1995Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and CanadaJ Natl Cancer Inst87652661PubMed

33.

Kristal, AR, Cohen, JH, Qu, P, Stanford, JL 2002Associations of energy, fat, calcium, and vitamin D with prostate cancer riskCancer Epidemiol Biomarkers Prev11719725PubMed

34.

Terry, P, Lichtenstein, P, Feychting, M, Ahlbom, A, Wolk, A 2001Fatty fish consumption and risk of prostate cancerLancet35717641766PubMedCrossRef

35.

Dwyer, JT 1997Human studies on the effects of fatty acids on cancer: summary, gaps, and future researchAm J Clin Nutr661581S1586SPubMed

36.

Cox, DR 1972Regression models and lifetables (with discussions)J R Stat Soc34187220

37.

Korn, EL, Graubard, BI, Midthune, D 1997Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scaleAm J Epidemiol1457280PubMed

38.

Willett, WC 1998Nutritional epidemiologyOxford University PressNew York, NY

39.

Godley, PA, Campbell, MK, Miller, C, Gallagher, P, Martinson, FE, Mohler, JL, Sandler, RS 1996Correlation between biomarkers of omega-3 fatty acid consumption and questionnaire data in African American and Caucasian United States males with and without prostatic carcinomaCancer Epidemiol Biomarkers Prev5115119PubMed

40.

Demark-Wahnefried, W, Price, DT, Polascik, TJ, Robertson, CN, Anderson, EE, Paulson, DF, Walther, PJ, Gannon, M, Vollmer, RT 2001Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic featuresUrology584752PubMedCrossRef

41.

Andersen, LF, Solvoll, K, Johansson, LR, Salminen, I, Aro, A, Drevon, CA 1999Evaluation of a food frequency questionnaire with weighed records, fatty acids, and alpha-tocopherol in adipose tissue and serumAm J Epidemiol1507587PubMed

42.

Larsson, SC, Kumlin, M, Ingelman-Sundberg, M, Wolk, A 2004Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanismsAm J Clin Nutr79935945PubMed

43.

Connolly, JM, Coleman, M, Rose, DP 1997Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude miceNutr Cancer29114119PubMedCrossRef

44.

Mori, T, Imaida, K, Tamano, S, Sano, M, Takahashi, S, Asamoto, M, Takeshita, M, Ueda, H, Shirai, T 2001Beef tallow, but not perilla or corn oil, promotion of rat prostate and intestinal carcinogenesis by 3,2’-dimethyl-4-aminobiphenylJpn J Cancer Res9210261033PubMed

45.

Rose, DP 1997Effects of dietary fatty acids on breast and prostate cancers: evidence from in vitro experiments and animal studiesAm J Clin Nutr661513S1522SPubMed

46.

Langelier, B, Furet, JP, Perruchot, MH, Alessandri, JM 2003Docosahexaenoic acid membrane content and mRNA expression of acyl-CoA oxidase and of peroxisome proliferator-activated receptor-delta are modulated in Y79 retinoblastoma cells differently by low and high doses of alpha-linolenic acidJ Neurosci Res74134141PubMedCrossRef

47.

Pandalai, PK, Pilat, MJ, Yamazaki, K, Naik, H, Pienta, KJ 1996The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growthAnticancer Res16815820PubMed

48.

du Toit, PJ, Aswegen, CH, du Plessis, DJ 1996The effect of essential fatty acids on growth and urokinase-type plasminogen activator production in human prostate DU-145 cellsProstaglandins Leukot Essent Fatty Acids55173177PubMedCrossRef

49.

Motaung, E, Prinsloo, SE, Aswegen, CH, du Toit, PJ, Becker, PJ, du Plessis, DJ 1999Cytotoxicity of combined essential fatty acids on a human prostate cancer cell lineProstaglandins Leukot Essent Fatty Acids61331337PubMedCrossRef

50.

Prinsloo, SE, Aswegen, CH 2002Effect of fatty acids on estradiol and testosterone binding to whole DU-145 prostate cellsProstaglandins Leukot Essent Fatty Acids66419425PubMedCrossRef

Title: A Prospective Study of Dietary Alpha-linolenic Acid and the Risk of Prostate Cancer (United States)
Authors: Daniel O. Koralek
Ulrike Peters
Gerald Andriole
Douglas Reding
Victoria Kirsh
Amy Subar
Arthur Schatzkin
Richard Hayes
Michael F. Leitzmann
Publication date: 01-08-2006
Publisher: Kluwer Academic Publishers
Published in: Cancer Causes & Control / Issue 6/2006
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-006-0014-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Objective

Design

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2006

Recreational Physical Activity and Prostate Cancer Risk (United States)

Re: Foulds and Ramstrom: Cancer Causes and Control 17: 227–228 (2006) and Henley et al., Cancer Causes and Control 16: 347–358 (2005). How Smokeless Tobacco can Cause Lung Cancer

Misclassification of race/ethnicity in a Population-based Cancer Registry (United States)

Potential Impact of Advanced Clinical Information Technology on Cancer Care in 2015

Response to: Foulds J and Ramstrom L Letter Regarding “Causal Effects of Smokeless Tobacco on Mortality in CPS-I and CPS-II”

Association of Reproductive Factors, Oral Contraceptive Use and Selected Lifestyle Factors with the Risk of Ovarian Borderline Tumors: A Danish Case-control Study

Keynote webinar | Spotlight on antibody–drug conjugates in cancer